2023. Prognostic Value And Clinical Impact Of EBV And PDL1 Expression In Classical Hodgkin Lymphoma. Journal of Pharmaceutical Negative Results. (Feb. 2023), 3461–3472. DOI:https://doi.org/10.47750/pnr.2023.14.02.406.